Urology · Dallas, TX
NPI
1790744829
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5323 Harry Hines Blvd
Dallas, TX, 75390
Phone (214) 645-8765
Groups this clinician bills Medicare through
Medicare paid, 2024
$271K
5,412 services
Medicare patients, 2024
463
Average age 73
Drug cost, 2024
$629K
1,372 prescriptions
Company payments, 2025
$116
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Margaret S Pearle was code J9030 (bcg live intravesical instillation, 1 mg), 1,300 times for 15 patients. In total Margaret S Pearle billed 5,412 services in 58 codes, and Medicare paid $271K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9030 Bcg live intravesical instillation, 1 mg | Office | 1,300 | 15 | $2.27 | $2,951 |
| 99214 Office E&M - Established | Office | 281 | 234 | $83.87 | $24K |
| J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | Office | 200 | 15 | $2.70 | $541 |
| 51720 Chemotherapy Administration | Office | 62 | 35 | $69.56 | $4,313 |
| 52310 Calculus Removal - Urinary | Office | 51 | 49 | $242.21 | $12K |
| 52356 Calculus Removal - Urinary | Facility | 48 | 44 | $323.79 | $16K |
| 99213 Office E&M - Established | Office | 45 | 42 | $56.66 | $2,550 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 39 | 39 | $12.51 | $488 |
| 52332 Cystourethroscopy | Facility | 29 | 25 | $84.49 | $2,450 |
| 52005 Cystourethroscopy | Facility | 28 | 27 | $56.37 | $1,578 |
| 50081 Other Organ Systems | Facility | 27 | 24 | $897.80 | $24K |
| 51705 Other Organ Systems | Office | 27 | 17 | $73.79 | $1,992 |
| 50437 Other Organ Systems | Facility | 25 | 23 | $97.90 | $2,447 |
| 99205 Office E&M - New | Office | 18 | 18 | $153.15 | $2,757 |
| 99215 Office E&M - Established | Office | 17 | 16 | $111.88 | $1,902 |
By year: 2022 $126K for 4,435 services; 2023 $125K for 5,329 services; 2024 $271K for 5,412 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 12 | 12 | $3.41 | $40.92 |
Medicare prescription drug claims, 2024
In 2024, the drug Margaret S Pearle prescribed most often to Medicare patients was Potassium Citrate Er (Potassium Citrate), with 435 prescriptions and refills. In total Margaret S Pearle wrote 1,372 Medicare prescriptions that cost $629K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Potassium Citrate Er Potassium Citrate | 435 | 1,174 | 145 | $64K |
| Indapamide Generic | 227 | 666 | 71 | $3,083 |
| Potassium Chloride Generic | 117 | 329 | 35 | $3,844 |
| Allopurinol Generic | 77 | 210 | 20 | $845 |
| Tamsulosin Hcl Generic | 74 | 126 | 52 | $566 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 59 | 59 | 44 | $454 |
| Thiola Ec Tiopronin | 58 | 58 | Under 11 | $480K |
| Oxybutynin Chloride Generic | 41 | 47 | 30 | $381 |
| Chlorthalidone Generic | 25 | 75 | Under 11 | $418 |
| Diclofenac Sodium Generic | 23 | 23 | 23 | $105 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 23 | 23 | 19 | $374 |
| Ciprofloxacin Hcl Generic | 21 | 21 | 15 | $115 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 21 | 21 | 16 | $67.37 |
| Fluconazole Generic | 13 | 13 | 11 | $81.18 |
| Methocarbamol Generic | 12 | 12 | Under 11 | $85.3 |
Brand drugs: - claims; generic drugs: 1,272 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Margaret S Pearle $116 ($116 in general payments such as food, travel and fees) from 2 companies. The largest payer was Cycle Pharmaceuticals Inc with $71.29.
| Company | Payments | Amount |
|---|---|---|
| Cycle Pharmaceuticals Inc | 4 | $71.29 |
| Novo Nordisk Inc NVO | 2 | $45.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.